Streetbeat News

Price Targets

CRH

Truist Securities analyst Keith Hughes has initiated coverage on CRH (NYSE:CRH) with a Buy rating and set a price target of $81.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 12:46 pm

PD

B of A Securities analyst Koji Ikeda has initiated coverage on PagerDuty (NYSE:PD) with a Buy rating and set a price target of $30.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 12:45 pm

CAH

Wells Fargo analyst Stephen Baxter has initiated coverage on Cardinal Health (NYSE:CAH) with an Underweight rating and set a price target of $96.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 12:43 pm

COR

Wells Fargo analyst Eric Luebchow has initiated coverage on Cencora (NYSE:COR) with an Equal-Weight rating and set a price target of $213.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 12:41 pm

IRWD

Wells Fargo analyst Mohit Bansal has initiated coverage on Ironwood Pharmaceuticals (NASDAQ:IRWD) with an Overweight rating and set a price target of $20.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 12:39 pm

MCK

Wells Fargo analyst Stephen Baxter has initiated coverage on McKesson Corporation (NYSE:MCK) with an Equal-Weight rating and set a price target of $502 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 12:34 pm

GDOT

Barclays analyst Ramsey El-Assal has downgraded Green Dot Corporation (NYSE:GDOT) from Equal-Weight to Underweight and set a new price target of $7. This change reflects a more bearish outlook on the company's stock by the analyst.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 12:20 pm

MAS

JP Morgan analyst Michael Rehaut has maintained a Neutral rating on Masco Corporation (NYSE:MAS) but increased the price target from $58 to $69.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 12:19 pm

ACHL

B of A Securities analyst Tazeen Ahmad has downgraded Achilles Therapeutics (ACHL) from Buy to Underperform, significantly reducing the price target from $7 to $0.5.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 12:18 pm

PGTI

JP Morgan analyst Michael Rehaut has maintained a Neutral rating on PGT Innovations (NYSE:PGTI) and increased the price target from $33 to $37.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 12:12 pm